Strata Skin Sciences (NASDAQ:SSKN) Stock Rating Lowered by Zacks Investment Research

Strata Skin Sciences (NASDAQ:SSKN) was downgraded by Zacks Investment Research from a “hold” rating to a “sell” rating in a report issued on Thursday, November 16th.

According to Zacks, “Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania. “

Other analysts have also recently issued reports about the company. HC Wainwright set a $12.00 price target on Strata Skin Sciences and gave the stock a “buy” rating in a research report on Friday, August 11th. ValuEngine upgraded Strata Skin Sciences from a “strong sell” rating to a “sell” rating in a research report on Friday, September 1st.

Shares of Strata Skin Sciences (NASDAQ SSKN) opened at $1.30 on Thursday. Strata Skin Sciences has a one year low of $1.06 and a one year high of $5.40. The company has a quick ratio of 1.07, a current ratio of 1.64 and a debt-to-equity ratio of 0.37.

COPYRIGHT VIOLATION NOTICE: “Strata Skin Sciences (NASDAQ:SSKN) Stock Rating Lowered by Zacks Investment Research” was first reported by Week Herald and is owned by of Week Herald. If you are reading this piece of content on another publication, it was illegally stolen and republished in violation of United States & international trademark and copyright legislation. The correct version of this piece of content can be read at https://weekherald.com/2017/12/04/strata-skin-sciences-inc-sskn-lowered-to-sell-at-zacks-investment-research.html.

About Strata Skin Sciences

STRATA Skin Sciences, Inc, formerly MELA Sciences, Inc, is a medical technology company. The Company is engaged in developing and commercializing products for the diagnosis and treatment of dermatological disorders. The Company has three segments: Dermatology Recurring Procedures, Dermatology Procedures Equipment and Dermatology Imaging.

Get a free copy of the Zacks research report on Strata Skin Sciences (SSKN)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Strata Skin Sciences Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Strata Skin Sciences Inc. and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply